Signal transducer and activator of transcription 3 in liver diseases: A novel therapeutic target

221Citations
Citations of this article
184Readers
Mendeley users who have this article in their library.

Abstract

Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that is activated by many cytokines and growth factors and plays a key role in cell survival, proliferation, and differentiation. STAT3 activation is detected virtually in all rodent models of liver injury and in human liver diseases. In this review, we highlight recent advances of STAT3 signaling in liver injury, steatosis, inflammation, regeneration, fibrosis, and hepatocarcino-genesis. The cytokines and small molecules that activate STAT3 in hepatocytes may have therapeutic benefits to treat acute liver injury, fatty liver disease, and alcoholic hepatitis, while blockage of STAT3 may have a therapeutic potential to prevent and treat liver cancer. © Ivyspring International Publisher.

Cite

CITATION STYLE

APA

Wang, H., Lafdil, F., Kong, X., & Gao, B. (2011). Signal transducer and activator of transcription 3 in liver diseases: A novel therapeutic target. International Journal of Biological Sciences. Ivyspring International Publisher. https://doi.org/10.7150/ijbs.7.536

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free